Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The autologous chondral platelet-rich plasma matrix implantation. A new therapy in cartilage repair and regeneration: macroscopic and biomechanical study in an experimental sheep model. | Front Vet Sci | 2023 | 38146499 | PubTator, text mining | PubMed |
| The Identification of Nuclear FMRP Isoform Iso6 Partners. | Cells | 2023 | 38132127 | PubTator, text mining | PubMed |
| Mapping the genetic and phenotypic landscape of neonatal C3 and C4 protein concentrations. | Cell Genom | 2023 | 38116124 | PubTator, text mining | PubMed |
| The correlates of neonatal complement component 3 and 4 protein concentrations with a focus on psychiatric and autoimmune disorders. | Cell Genom | 2023 | 38116117 | PubTator, text mining | PubMed |
| Insight into the mechanism of gallstone disease by proteomic and metaproteomic characterization of human bile. | Front Microbiol | 2023 | 38111640 | PubTator, text mining | PubMed |
| Multifactorial Comparative Analysis of Platelet-Rich Plasma and Serum Prepared Using a Commercially Available Centrifugation Kit. | Cureus | 2023 | 38106812 | PubTator, text mining | PubMed |
| Urinary Protein-Biomarkers Reliably Indicate Very Early Kidney Damage in Children With Alport Syndrome Independently of Albuminuria and Inflammation. | Kidney Int Rep | 2023 | 38106579 | PubTator, text mining | PubMed |
| Targeting complement in IgA nephropathy. | Clin Kidney J | 2023 | 38053977 | PubTator, text mining | PubMed |
| Upregulation of S100A8 in peripheral blood mononuclear cells from patients with depression treated with SSRIs: a pilot study. | Proteome Sci | 2023 | 38049858 | PubTator, text mining | PubMed |
| Red Wine Inspired Chemistry: Hemisynthesis of Procyanidin Analogs and Determination of Their Protein Precipitation Capacity, Octanol-Water Partition, and Stability in Phosphate-Buffered Saline. | J Agric Food Chem | 2023 | 38048420 | PubTator, text mining | PubMed |
| Residual serum fibrinogen as a universal biomarker for all serotypes of Myasthenia gravis. | Sci Rep | 2023 | 38040826 | PubTator, text mining | PubMed |
| Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease. | Front Endocrinol (Lausanne) | 2023 | 38034020 | PubTator, text mining | PubMed |
| Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 38003705 | PubTator, text mining | PubMed |
| An Overview of Recent Developments in the Management of Burn Injuries. | Int J Mol Sci | 2023 | 38003548 | PubTator, text mining | PubMed |
| Molecular EPISTOP, a comprehensive multi-omic analysis of blood from Tuberous Sclerosis Complex infants age birth to two years. | Nat Commun | 2023 | 37996417 | PubTator, text mining | PubMed |
| Comparison of in-gel and in-solution proteolysis in the proteome profiling of organ perfusion solutions. | Clin Proteomics | 2023 | 37968584 | PubTator, text mining | PubMed |
| New Potentiality of Bioactive Substances: Regulating the NLRP3 Inflammasome in Autoimmune Diseases. | Nutrients | 2023 | 37960237 | PubTator, text mining | PubMed |
| Regulation of the innate immune system by fragmented heparin-conjugated lipids on lipid bilayered membranes in vitro. | J Mater Chem B | 2023 | 37953734 | PubTator, text mining | PubMed |
| Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders. | Mol Neurodegener | 2023 | 37941028 | PubTator, text mining | PubMed |
| Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure. | J Transl Med | 2023 | 37936122 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=8